Two-thirds of visually estimated lesions result in inappropriate stent length selection,1 which negatively impacts outcomes. These patients are more than twice as likely to require target-vessel revascularization within one year and three times as likely to have an myocardial infarction within three years.2
CorPath GRX allows for instantaneous sub-mm measurement of anatomy and precise device positioning with 1mm movements. This may reduce measurement errors, the need for extra stents, and the incidence of longitudinal geographic miss.1
This exclusive paper explores questions around robotic-assisted PCI and how it may improve stent placement. Why can’t we fully rely on what we see? How can robotic precision improve stent placement and therefore quality of care? Is robotics worth the investment? Explore the answers to these questions and see how robotic assistance may add value by increasing precision and improving quality of care.
Campbell PT, et al. The Impact of Precise Robotic Lesion Length Measurement on Stent Length Selection: Ramification for stent savings. Cardiovasc Revasc Med. 2015
Costa M A, Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial), *American Journal of Cardiology 2008